tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market
Advertisement

Vertex Pharmaceuticals (VRTX) Ratios

Compare
6,433 Followers

Vertex Pharmaceuticals Ratios

VRTX's free cash flow for Q3 2025 was $0.87. For the 2025 fiscal year, VRTX's free cash flow was decreased by $ and operating cash flow was $0.42. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.36 3.99 5.22 4.81 5.02
Quick Ratio
2.00 3.78 5.03 4.62 4.84
Cash Ratio
1.10 2.92 4.32 3.63 3.84
Solvency Ratio
0.51 0.74 0.82 0.74 0.92
Operating Cash Flow Ratio
0.83 1.00 1.70 1.41 2.09
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 -10.25
Net Current Asset Value
$ 3.03B$ 8.99B$ 8.44B$ 5.68B$ 4.76B
Leverage Ratios
Debt-to-Assets Ratio
0.07 0.04 0.03 0.04 0.05
Debt-to-Equity Ratio
0.07 0.05 0.04 0.06 0.07
Debt-to-Capital Ratio
0.07 0.04 0.04 0.05 0.06
Long-Term Debt-to-Capital Ratio
0.07 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.00 1.29 1.30 1.33 1.35
Debt Service Coverage Ratio
299.46 87.19 64.33 41.13 -11.11
Interest Coverage Ratio
311.98 86.89 78.60 45.24 49.12
Debt to Market Cap
0.02 0.00 0.00 0.00 >-0.01
Interest Debt Per Share
7.23 3.31 2.40 2.40 2.46
Net Debt to EBITDA
-0.67 -2.08 -2.24 -2.14 -1.65
Profitability Margins
Gross Profit Margin
86.28%87.21%87.90%88.06%88.14%
EBIT Margin
38.06%44.83%48.01%36.86%51.16%
EBITDA Margin
39.30%46.66%49.67%38.52%52.93%
Operating Profit Margin
34.06%38.83%48.23%36.73%46.03%
Pretax Profit Margin
37.95%44.38%47.39%36.05%50.22%
Net Profit Margin
31.35%36.68%37.20%30.92%43.70%
Continuous Operations Profit Margin
31.35%36.68%37.20%30.92%43.70%
Net Income Per EBT
82.61%82.64%78.49%85.78%87.00%
EBT Per EBIT
111.40%114.30%98.26%98.14%109.12%
Return on Assets (ROA)
14.78%15.92%18.30%17.44%23.07%
Return on Equity (ROE)
19.62%20.59%23.88%23.19%31.22%
Return on Capital Employed (ROCE)
19.59%19.98%27.40%24.07%28.03%
Return on Invested Capital (ROIC)
16.18%16.44%21.38%20.50%25.06%
Return on Tangible Assets
15.74%17.40%20.18%19.47%26.20%
Earnings Yield
3.45%3.45%4.49%4.14%4.42%
Efficiency Ratios
Receivables Turnover
6.02 6.31 6.19 6.66 7.01
Payables Turnover
0.40 3.46 3.55 4.64 4.75
Inventory Turnover
0.99 1.71 2.35 2.56 2.62
Fixed Asset Turnover
3.89 6.79 8.06 6.92 6.47
Asset Turnover
0.47 0.43 0.49 0.56 0.53
Working Capital Turnover Ratio
1.89 0.94 1.03 1.13 1.28
Cash Conversion Cycle
-485.53 165.94 111.89 118.60 114.36
Days of Sales Outstanding
60.60 57.82 58.94 54.78 52.07
Days of Inventory Outstanding
369.11 213.64 155.62 142.54 139.19
Days of Payables Outstanding
915.23 105.52 102.68 78.72 76.91
Operating Cycle
429.71 271.46 214.57 197.32 191.26
Cash Flow Ratios
Operating Cash Flow Per Share
14.55 13.73 16.13 10.26 12.52
Free Cash Flow Per Share
13.06 12.72 15.33 9.35 11.52
CapEx Per Share
1.49 1.00 0.80 0.91 1.00
Free Cash Flow to Operating Cash Flow
0.90 0.93 0.95 0.91 0.92
Dividend Paid and CapEx Coverage Ratio
9.76 13.69 20.18 11.25 12.52
Capital Expenditure Coverage Ratio
9.76 13.69 20.18 11.25 12.52
Operating Cash Flow Coverage Ratio
2.03 4.38 7.36 4.75 5.60
Operating Cash Flow to Sales Ratio
0.32 0.36 0.46 0.35 0.52
Free Cash Flow Yield
3.12%3.13%5.31%4.26%4.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.95 28.97 22.26 24.16 22.65
Price-to-Sales (P/S) Ratio
9.11 10.62 8.28 7.47 9.90
Price-to-Book (P/B) Ratio
4.28 5.96 5.32 5.60 7.07
Price-to-Free Cash Flow (P/FCF) Ratio
32.01 31.98 18.84 23.50 20.51
Price-to-Operating Cash Flow Ratio
28.62 29.64 17.91 21.41 18.88
Price-to-Earnings Growth (PEG) Ratio
21.54 3.48 0.52 -1.87 0.18
Price-to-Fair Value
4.28 5.96 5.32 5.60 7.07
Enterprise Value Multiple
22.51 20.69 14.43 17.26 17.05
Enterprise Value
103.71B 95.29B 64.01B 50.35B 56.00B
EV to EBITDA
22.51 20.69 14.43 17.26 17.05
EV to Sales
8.85 9.66 7.17 6.65 9.02
EV to Free Cash Flow
31.08 29.06 16.31 20.91 18.71
EV to Operating Cash Flow
27.90 26.94 15.50 19.05 17.21
Tangible Book Value Per Share
61.82 60.74 47.72 32.20 26.50
Shareholders’ Equity Per Share
97.27 68.22 54.33 39.19 33.43
Tax and Other Ratios
Effective Tax Rate
0.17 0.17 0.22 0.14 0.13
Revenue Per Share
45.87 38.30 34.87 29.39 23.88
Net Income Per Share
14.38 14.05 12.97 9.09 10.44
Tax Burden
0.83 0.83 0.78 0.86 0.87
Interest Burden
1.00 0.99 0.99 0.98 0.98
Research & Development to Revenue
0.34 0.32 0.28 0.40 0.29
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.06 0.06 0.06 0.06 0.07
Income Quality
1.01 0.98 1.24 1.13 1.20
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis